Dr. Mamdooh Ghoneum today will discuss his findings on cancer research and treatment at the Egyptian Embassy in Washington, D.C.
The event, sponsored by the Egyptian Cultural and Educational Bureau, will run from 6 p.m. to 8 p.m., followed by a reception.
Ghoneum, an Egyptian-born researcher and professor at Charles Drew University of Medicine and Science in Los Angeles, has been studying natural cures for cancer for more than two decades. His research has centered on a critical theory: That cancer cells, when exposed to small amounts of yeast, have died.
"I have no doubt that I am close to unlocking the mystery as to why cancer cells weaken to the point of destruction after eating common baker's yeast," Dr. Ghoneum said earlier this year. "The cells just gravitate to the yeast. I call it fatal attraction."
His recent experiments have shown that yeast created significant clearance when cancer cells metasized to lungs in mice. His research in previous years has shown that tumors in mice decreased in size when injected with yeast. Lately, Dr. Ghoneum has focused on figuring out how much yeast can be considered a safe and effective dosage.
His research has been reproduced by scientists worldwide, with results published in leading medical journals. The immunologist's research also has been affirmed at the U.S. Department of Health and Science, National Institute of Health.
Dr. Ghoneum earned his Ph.D at the University of Tokyo in 1980 and completed his postdoctoral studies at UCLA.
Reservations for today's event can be made at the embassy, located at 3521 International Court N.W. in Washington, by calling 202-296-3959 or by sending an email to eecous@eecous.net.
About Charles Drew University of Medicine and Science: CDU is a private nonprofit, nonsectarian, minority-serving medical and health sciences institution. Located in the Watts-Willowbrook area of South Los Angeles, CDU has graduated more than 550 medical doctors, 2,500 post-graduate physicians, more than 2,000 physician assistants and hundreds of other health professionals. The only dually designated Historically Black Graduate Institution and Hispanic Serving Health Professions School in the U.S. CDU is recognized as a leader in translational and health inequities research, specifically with respect to heart disease, diabetes, cancer, mental health, and HIV/AIDS. The university is among the top 7 percent of National Institutes of Health-funded institutions and rated one of the top 50 private universities in research in the U.S. Recently, the CDU/UCLA medical program was named the "best performer" in the University of California System with respect to producing outstanding underrepresented minority physicians. For more information, visit http://www.cdrewu.edu.